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Perception of burden experienced during diagnostic tests
by melanoma patients with lymph node metastases
Esther Bastiaanneta,e, Josette E. Hoekstra-Weebersb,e,
Anne Brecht Franckena, Piet L. Jagerc, Eric J. van der Jagtd
and Harald J. Hoekstraa
Melanoma patients with lymph node metastases have to
deal with diagnostic tests to exclude the presence of
distant metastases; results of the tests could have major
implications for their prognosis and treatment. There
are, however, few studies concerning the patients’
psychological issues and perception of diagnostic tests.
The aim of this study was to describe the burden of
diagnostic tests [radiograph, computed tomography
(CT) and positron emission tomography (PET)]
experienced by melanoma patients with lymph
node metastases. Patients were asked to complete
a questionnaire concerning satisfaction and burden
experienced during the diagnostic tests. The levels of
embarrassment, discomfort and anxiety for the different
tests, as well as total scores for each burden were
calculated. Logistic regression was used to examine
factors associated with the degree of experienced burden.
Fifty-nine of the 68 patients completed the questionnaire
and the response rate was 87%. The overall mean scores
on satisfaction and quality of life were high. More than half
of the patients experienced no burden during PET, 65% no
burden during computed tomography and 80% no burden
during chest radiograph. Patients experienced significantly
more discomfort during the PET scan than during the CT
(P=0.003). Less burden was experienced (in univariate
analysis) by patients who were more satisfied. The overall
experienced burden by patients is low and should
therefore not interfere with primary choice for a diagnostic
test based on accuracy, costs and percentage of patients
upstaged. Attention should be paid in explaining the
procedure and answering questions of the patients to
reduce burden. Melanoma Res 19:36–41 c 2009 Wolters
Kluwer Health | Lippincott Williams & Wilkins.
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Introduction
The incidence of melanoma is one of the most rapidly
increasing types of cancer [1]. The incidence in The
Netherlands in 2003 was 16.1 per 100 000; a rise of 41%
compared to the incidence in 1992. Increased awareness
and surveillance have resulted in earlier diagnosis of
melanoma and, consequently, the melanoma patient is
now diagnosed at an earlier stage of disease [2]. Never-
theless, some melanoma patients still present or recur
with loco-regional metastases (American Joint Commis-
sion on Cancer stage III). When no distant metastases are
detected, the standard of care for these patients is a
surgical excision of the primary tumour and a lymph node
dissection. Several imaging techniques, such as radio-
graph of the chest, computed tomography (CT), and
positron emission tomography (PET), are available to
detect distant metastases. Defining the additional value
of these diagnostic tests requires an evaluation of the
accuracy, the impact on treatment, and the costs of the
tests. As the value of PET and spiral CT for melanoma
patients clinically stage III is not clear, a prospective
multicentre study in The Netherlands was undertaken.
Additionally, burden experienced by the patients could
be an important feature in defining the value of these
diagnostic tests.
Considering the increased incidence of melanoma, there
are only a few studies concerning the psychological issues
and perception of diagnostic tests related to this disease,
often with contradicting results. Studies have reported
that newly diagnosed melanoma patients (stage I)
exhibited the same psychological distress as other cancer
patients, despite a good prognosis [3,4] Other studies,
however, found that melanoma patients do not differ from
the general public in terms of emotional well-being and
even that their psychological functioning was superior to
that of other dermatology patients [5]. Participants with a
hereditary risk of melanoma in a melanoma prevention
programme showed relatively low levels of psychological
problems, whereas participants in public screening
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revealed higher levels of problems [6,7] Considerable sex
differences were found in this last study; women were
more concerned, had higher levels of anxiety, tiredness
and psychosomatic complaints [7]. A delay in diagnostics
was also reported to be significantly more distressing for
females than for males [8].
Some studies have shown anxiety-related reactions in
patients undergoing MRI [9–11]. Patients who experi-
ence such feelings may disrupt the examination or move,
which may cause a degradation of the images. Anxiety-
related reactions may also influence patients’ perception
concerning their care [9]. Additionally, information about
patients’ preferences is necessary to be able to assist
patients in making decisions about which tests to
undergo, as patients may prefer an active role in test
and treatment decision-making [12,13]. Patients with
lymph node metastases have to deal with more diagnostic
tests to prove or exclude the presence of distant
metastases. The results of the tests could have major
implications for prognosis and treatment. Therefore,
the aim of this study was to describe and compare the
perception, both satisfaction and burden, of the diag-
nostic tests (chest radiograph, CTand PET) of melanoma
patients with lymph node metastases.
Patients and methods
From September 2004 to November 2006, patients with
clinical stage III melanoma were included in a prospec-
tive study to determine the value of PETwith the tracer
fluorodeoxyglucose (FDG) and CT. If patients showed no
distant metastases on CTand PET, they were questioned
about different aspects related to the diagnostic tests.
They received a questionnaire 2–6 weeks after lymph
node dissection.
Diagnostic tests
Some patients had a standard chest radiograph taken
before the other diagnostic tests. All patients underwent
at least a multidetector spiral CT and PET to prove or
exclude the presence of distant metastases.
Computed tomography
The examination was performed with a multidetector
spiral CT with at least four detector rows. Patients had
to drink 800ml oral contrast in four portions before the
CT examination. First, a chest CT was performed with
intravenous contrast, followed by an abdomen CT. If the
lymph node metastases were located in the neck, CT of
the neck was performed with intravenous contrast. Total
investigation time is 5–10min. The CT results were
examined by experienced radiologists.
Positron emission tomography
After a 6 h or overnight fasting period, patients were
intravenously injected with 220–650MBq and prehy-
drated with 500–1500ml water. The interval between the
FDG injection and the PET scan was 60–90min. When
specially indicated, furosemide or bed rest was given.
Patients were scanned from the midfemoral region until
the skull (two-dimensional or three-dimensional acqui-
sitions). Emission scan duration was 5min per bed
position, transmission imaging 3min. The total duration
of the procedure was approximately 2 h and 30min
including a scan time of approximately 1 h.
Questionnaire
Patients were asked to complete a self-administrated
questionnaire. The following sociodemographic informa-
tion was gathered: date of birth, sex, marital status,
education and occupational status. Eleven questions
assessed patients’ satisfaction with care and with all the
diagnostic tests combined. A high score corresponds with
high satisfaction (see Table 2) [14]. For each diagnostic
test (chest radiograph, CT scan and PET scan), the
following questions were asked: (i) how much embarrass-
ment, (ii) discomfort and (iii) anxiety did you experience
during the test and (iv) would you recommend the test
to a friend. These questions were also used in other
studies (Westerterp et al., 2007, in preparation) [9–11,15].
Questions concerning the burden had to be answered on
a 5-point scale, with 1 indicating ‘none’, 2 ‘mild’, 3
‘moderate’, 4 ‘severe’ and 5 indicating ‘extreme’ and were
followed by the question of why patients felt that way.
Finally, patients were asked to rank the different
diagnostic tests, questions were asked about the length
of the tests, how they felt about having to travel to the
hospital on two different days and whether they had
come with their partner, family or friends. At the end of
the questionnaire, we left space for patients’ comments.
The levels of embarrassment, discomfort and anxiety
for the different tests, as well as total scores for each
burden were calculated. Correlation was assessed be-
tween quality of life (QoL) as scored by the patient, and
the preference for decision-maker. Differences in embar-
rassment, discomfort and anxiety during the tests were
calculated (Wilcoxon for two groups and Friedman test
for the three groups). Regression analysis was used to
examine the factors, which affected the degree to which
patients experienced burden. P values <0.05 were
considered statistically significant.
Results
Fifty-nine of 68 patients completed the questionnaire;
the response rate was 87%. Male and female patients
were almost equally represented. The median age of the
included patients was 58.6 (range 29–85) years. Most of
the patients were married (69%) or cohabiting and almost
half had finished middle/higher secondary or middle
vocational school. Almost a third of the patients had a
full-time job or was retired (Table 1).
The overall scores on satisfaction and QoL were high
(Table 2). Satisfaction with the amount of information
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that was given to the patients received the highest score.
Second was satisfaction concerning the doctors’ will-
ingness and patience to answer questions. Patients were
highly satisfied if they felt that all their questions were
answered and the procedure and reason for the test were
explained. A mean score of 4.4 was reported concerning
the satisfaction of patients with the amount of time and
attention given to them and the satisfaction concerning
the support given. Patients were also satisfied with the
weight that was given to their opinion in the decision-
making. The mean score for the satisfaction with quickness
of help was also relatively high. The lowest score was in
the satisfaction with the amount of space patients were
given to make their own decisions. A high mean score was
reported for patients’ satisfaction with the amount of
information they received about their medical situation.
The overall mean satisfaction with the course of the
diagnostic tests was 8.0.
Most patients thought the decisions about their treat-
ment had to be made by the doctor and the patient
collaboratively, 20% preferred the doctor to be the
predominant decision-maker, 9% preferred the patient
to be the predominant decision-maker and only a few
patients preferred the doctor to be the sole decision-
maker. The mean QoL was 7.5; four patients judged
their QoL lower than 6. In this study, there was a signi-
ficant correlation between the reported QoL and the
preference for decision-maker: the larger the doctor’s
role in making the decision, the higher the patient’s
QoL (r= –0.38; P=0.004). Additionally, older age was
associated with preference for the doctor to make the
decision (P=0.01).
Table 3 shows the amount of embarrassment, discomfort
or anxiety patients felt during the diagnostic tests. Of
the 40 patients who had a chest radiograph, 35 (87.5%)
felt no embarrassment. Five patients (12.5%) felt mild-
to-extreme embarrassed: two for being nude from the
waist up, two because they were not sure what to do and
one patient was anxious about the test results during the
chest radiograph. No discomfort during the chest radio-
graph was reported by 36 patients (90%). Four patients
(10%) felt mild-to-moderate discomfort during the chest
radiograph; reasons that were mentioned were having
to hold their breath for a longer time, being cold, feeling
nervous or pain in the shoulder. Thirty-two patients
Table 1 Demographic characteristics of the patients
Characteristic N %
Sex Male 33 55.9
Female 26 44.1
Age r45 years 15 25.4
46–64 years 29 49.2
Z65 years 15 25.4
Marital status Married 40 69.0
No relationship, living alone 9 15.5
Relationship, living alone 3 5.2
Divorced or widower 6 11.3
Highest education Primary school/Lower vocational
school
20 33.9
Middle/higher secondary or middle
vocational school
28 47.5
Higher vocational school/university 11 18.6
Occupation Full-time job 18 30.5
Part-time job 11 18.7
Housekeeping 7 11.9
Retired 17 28.8
Unable to work 6 10.2
Table 2 Reported scores concerning the satisfaction of the
patients, QoL and preference for decision-maker (part 2 of the
questionnaire)
Satisfaction of patients Mean±SD
Possible range 0–5 Amount of information given 4.8±0.6
Willingness and patience of doctors in answering
your questions
4.7±0.8
Answers to all your questions 4.6±0.9
Explanation of the procedure and the reason
for the test
4.6±0.9
Time and attention given to you 4.4±1.0
The support given 4.4±1.1
The weight of your own opinion in decisions 4.3±0.6
Quick help 4.1±1.2
To make own decisions 3.5±0.8
Possible range 0–10
The amount of medical information you would
like to have
8.9±1.6
Overall satisfaction with diagnostic tests 8.0±1.6
QoL
How would you judge your QoL? 7.5±1.5
Decision-maker
Who would you prefer to make the decision:
the doctor or you?
Only the doctor: 3 (5.1%)
Predominantly the
doctor: 12 (20.3%)




Only the patient: 0
QoL, quality of life.
Table 3 Number of patients who felt none to extreme
embarrassment, discomfort and anxiety during the chest
radiograph, PET and CT scans
Radiograph CT
N (%) N (%)
FDG–PET
N (%)
Embarrassment None 35 (87.5) 38 (65.5) 36 (61.0)
Mild 3 (7.5) 14 (24.1) 15 (25.4)
Moderate 1 (2.5) 3 (5.2) 4 (6.8)
Severe 1 (2.5) 1 (1.7) 2 (3.4)
Extreme – 2 (3.5) 2 (3.4)
Discomfort None 36 (90.0) 38 (65.5) 25 (42.4)
Mild 3 (7.5) 18 (31.0) 27 (45.8)
Moderate 1 (2.5) – 5 (5.8)
Severe – 1 (1.7) –
Extreme – 1 (1.8) 2 (3.4)
Anxiety None 32 (80.0) 40 (69.0) 38 (64.4)
Mild 3 (7.5) 11 (19.0) 11 (18.6)
Moderate 3 (7.5) 4 (6.9) 5 (8.5)
Severe 2 (5.0) 1 (1.7) 4 (6.8)
Extreme – 2 (3.4) 1 (1.7)
CT, computed tomography; FDG, fluorodeoxyglucose; PET, positron emission
tomography.
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(80%) reported no anxiety during the chest radiograph.
Eight patients (20%) reported anxiety about the results
of the chest radiograph.
No embarrassment during the CT scan was reported by
38 patients (65.5%). Twenty patients were, however,
mild-to-extreme embarrassed during the CT scan, mainly
because they did not know what to do and they had
trouble lying still. Discomfort during the CT scan was
not reported by 38 patients (65.5%). Twenty patients
experienced discomfort during the CTscan; again a larger
percentage found it difficult to lay still and others felt
cold. Forty patients (69%) experienced no anxiety during
the CT scan; 18 (31%) experienced some kind of anxiety
because they were anxious about the results or claus-
trophobic (extreme anxiety).
No embarrassment during the PET scan was reported
by 36 patients (61%). Twenty-three patients (39%) were
embarrassed during the PET scan, mainly because they
did not know what to do or they had trouble lying still.
Discomfort during the PET scan was not reported by 25
patients (42.2%). Thirty-four patients (58%), however,
reported discomfort (trouble lying still, feeling cold and
discomfort from having a full bladder). Thirty-eight
patients (64.4%) felt no anxiety during the PET scan.
Twenty-one patients (35%) were anxious during the PET
scan; patients were anxious about the test results and felt
claustrophobic.
Overall, more than half of the patients experienced no
burden during the PET scan, more than 65% of the
patients experienced no burden during the CT and more
than 80% experienced no burden during the chest
radiograph. Patients who experienced anxiety during
one of the diagnostic tests, experienced anxiety during
all tests (correlation CT and PET P<0.001; CT and
radiograph P=0.0006; PET and radiograph P=0.003).
Patients who experienced discomfort during the PET
scan experienced discomfort during the CT scan
(P=0.001). Additionally, patients who experienced
embarrassment during the CT also felt embarrassed
during the PET (P<0.0001) and radiograph (P=0.01).
Patients experienced significantly more discomfort during
the PET scan than during the CT scan (P=0.003).
Despite this burden, all patients indicated that they
would recommend the tests to a friend if they were
advised to go for one. Less burden was experienced by
patients who felt satisfied that the procedure was
explained (P<0.001), doctors were willing and patience
(P=0.002), questions were answered (P=0.011), atten-
tion was given (P=0.006), enough support was given
(P=0.001) and that enough medical information was
given (P=0.018). Additionally, patients who were more
overall satisfied (P=0.006) and patients who reported a
higher QoL (P=0.002) also reported less burden in
univariate analysis. Age (P=0.22), sex (P=0.07), marital
status (P=0.83) and education (P=0.67) were not
statistically significant associated with burden. In addi-
tion, time from lymph node dissection to filling in
the questionnaire was not associated with the burden
experienced (P=0.168). In multivariate analysis, none of
the variables was significantly associated with burden.
Most patients ranked the PETscan as most inconvenient,
25% thought there was no difference in inconvenience
between the diagnostic tests. The length of the PETscan
was experienced as rather long or very long by 51.7% of
the patients, the CT scan by two patients. The fact that
the tests could not be performed in 1 day was no problem
to 48% of the patients, a small problem to 36% and nine
patients reported it being very unpleasant. Having to
travel to the hospital was no problem for 56% of the
patients, a small problem for 37% and very unpleasant
for 7%. Only three patients came to the test alone, the
remaining came with their spouse (61.4%), with family
members (26.3%) or with spouse and family members or
a friend (7.0%).
Discussion
In the last 15 years, QoL has been identified as an
important outcome for cancer patients. The amount of
emotional distress the patient experiences is an impor-
tant component of that QoL [16]. The psychosocial
demands that confront cancer patients vary over the
course of the illness; however, the time of diagnosis is
described as particularly distressing [17–19]. Additionally,
younger cancer patients face more difficulties when they
receive a cancer diagnosis than older patients [20]. As the
incidence of melanoma continues to increase and the age
at which it is diagnosed continues to decrease, more and
more younger patients will be referred to the oncology
clinics [16].
In this study, more than half of the patients experienced
no burden during the PET, more than 65% no burden
during the CT and more than 80% no burden during the
chest radiograph. Patients experienced significantly more
discomfort during the PETscan compared to the CTscan
(P=0.003). Patients who were more satisfied, experi-
enced less burden during the diagnostic tests (univariate
analysis).
Patients in this study were very satisfied with various
aspects concerning the diagnostic tests. Patients seem to
be the most satisfied with the amount of information that
was provided to them, the willingness and patience of the
doctors to answer questions. A high score was reported
when patients were satisfied with how quickly they were
helped, despite the fact that a few patients mentioned
that the time between the diagnostic tests and the
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operation was long. Patients were least satisfied with the
amount of space that was given to them to make their
own decisions. Mainly, patients who scored low on this
question felt that the doctor and patient had to make the
decisions together. Additionally, we found a significant
correlation between QoL and decision-maker: patients
who left the decision entirely to the doctor or pre-
dominantly to the doctor reported a higher QoL in
this study.
Several studies have been carried out to evaluate anxiety-
related reactions associated with MRI [9,10,21]. A
Canadian review reported that anxiety-related reactions
occur in approximately 4–30% of the patients undergoing
MRI, ranging from apprehension to severe reactions,
which interfered with the performance of the test [10].
Criteria for diagnosis and categorization of the reactions
and identification of patients at risk are scarce, although
management strategies such as patient education, drug
therapy and cognitive-behavioral intervention have been
proposed [10]. A recent prospective study in patients
at risk for colorectal cancer showed that patients prefer-
red CTcolonography above colonoscopy. This preference,
however, decreased over time, and outcome considera-
tions gradually replaced temporary experiences of incon-
venience [15]. It is likely that future decisions will be
based on the final opinion, as this opinion is formed after
immediate experiences have tempered and when patients
have returned to normal functioning. The researchers
assumed that experience and preference are preferably
measured after a certain time, as this may better reflect
future behaviour than if experience and preference are
measured under stressful circumstances [15]. In this
study, we chose a 2–6 week interval after surgery and
found no association between time since operation to
questionnaire and burden. However, it remains unknown
when opinions change and which interval should be used
to optimally measure patient preference.
In this study most of the patients experienced discom-
fort, particularly during the PET scan. This is probably
because of the fact that patients have to lay still for a
longer period of time as during a CT scan. Future PET–
CT scanners could correct this discomfort as they can
scan a patient in less than 30min, or even in 10min if
more FDG is injected. Furthermore, patients who felt
they were not sufficiently informed about the procedure
or were cold felt embarrassed and discomfort; burdens
that probably could be avoided.
Several limitations to the study should be noted. First, it
is not possible to determine whether the nonresponders
were less satisfied or experienced more burdens from
the diagnostic tests. Second, the questionnaires were only
sent to a relatively small sample of patients who showed
no distant metastases on PET and CT scans. It could be
that patients who had distant metastases experienced
more burden from the diagnostic tests; future studies
should compare these two groups. To our knowledge,
however, this is the first study to investigate the patients’
perceptions of the diagnostc tests FDG–PET, CT and
chest radiograph, and, therefore, the results could be
of great interest. The findings cannot be representative
for all melanoma patients, but they do highlight salient
issues in an area where research has been lacking.
In conclusion, although patients experience more dis-
comfort during the PET scan, the overall levels of
moderate-to-extreme embarrassment, discomfort and
anxiety were low. The accuracy, costs and the percentage
of patients upstaged will probably be the most important
outcomes to determine the additional value of FDG–PET
and CT, but it is reassuring to know that the overall
burden of these diagnostic tests is low.
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